Literature DB >> 2841157

Leukotriene B4 increases the lymphocyte binding to endothelial cells.

R Renkonen1, P Mattila, D Leszczynski, P Häyry.   

Abstract

Leukotrienes are potent mediators of local microvascular environment. Leukotriene B4 treatment of cultured endothelium increases the binding of lymphocytes to endothelial cell monolayers within minutes. This effect is dose-dependent and reversible upon removal of the leukotriene. Pretreatment of lymphocytes slightly decreases the binding and pretreatment of both lymphocytes and endothelium with leukotriene B4 prior to the adherence assay did not alter the binding. These results suggest that leukotriene B4 regulates exclusively the vascular side, but not the white cell side of this interaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841157     DOI: 10.1016/0014-5793(88)81235-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection.

Authors:  R Renkonen; J P Turunen; J Rapola; P Häyry
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

2.  Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cells.

Authors:  S S To; L Schrieber
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.